These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 30538114)

  • 1. GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.
    Jung M; Cordes S; Zou J; Yu SJ; Guitart X; Hong SG; Dang V; Kang E; Donaires FS; Hassan SA; Albitar M; Hsu AP; Holland SM; Hickstein DD; Townsley D; Dunbar CE; Winkler T
    Blood Adv; 2018 Dec; 2(23):3553-3565. PubMed ID: 30538114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of two heterozygous GATA2 CRISPR/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency.
    Castaño J; Romero-Moya D; Richaud-Patin Y; Giorgetti A
    Stem Cell Res; 2021 Aug; 55():102445. PubMed ID: 34284273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA2 Promotes Hematopoietic Development and Represses Cardiac Differentiation of Human Mesoderm.
    Castaño J; Aranda S; Bueno C; Calero-Nieto FJ; Mejia-Ramirez E; Mosquera JL; Blanco E; Wang X; Prieto C; Zabaleta L; Mereu E; Rovira M; Jiménez-Delgado S; Matson DR; Heyn H; Bresnick EH; Göttgens B; Di Croce L; Menendez P; Raya A; Giorgetti A
    Stem Cell Reports; 2019 Sep; 13(3):515-529. PubMed ID: 31402335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the Hematopoietic Stem Cell Factor GATA2 in the Osteogenic Lineage Impairs Trabecularization and Mechanical Strength of Bone.
    Tolkachov A; Fischer C; Ambrosi TH; Bothe M; Han CT; Muenzner M; Mathia S; Salminen M; Seifert G; Thiele M; Duda GN; Meijsing SH; Sauer S; Schulz TJ; Schupp M
    Mol Cell Biol; 2018 Jun; 38(12):. PubMed ID: 29581184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA2 and marrow failure.
    Fabozzi F; Strocchio L; Mastronuzzi A; Merli P
    Best Pract Res Clin Haematol; 2021 Jun; 34(2):101278. PubMed ID: 34404529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis.
    van Lier YF; de Bree GJ; Jonkers RE; Roelofs JJTH; Ten Berge IJM; Rutten CE; Nur E; Kuijpers TW; Hazenberg MD; Zeerleder SS
    Clin Immunol; 2020 Sep; 218():108522. PubMed ID: 32682923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient commitment to functional CD34+ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cells.
    Xu Y; Liu L; Zhang L; Fu S; Hu Y; Wang Y; Fu H; Wu K; Xiao H; Liu S; Yu X; Zheng W; Feng B; Huang H
    PLoS One; 2012; 7(4):e34321. PubMed ID: 22496789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in GATA2 deficiency.
    Wu Z; Gao S; Diamond C; Kajigaya S; Chen J; Shi R; Palmer C; Hsu AP; Calvo KR; Hickstein DD; Holland SM; Young NS
    Blood Adv; 2020 Jun; 4(12):2656-2670. PubMed ID: 32556286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline GATA2 Mutation and Bone Marrow Failure.
    McReynolds LJ; Calvo KR; Holland SM
    Hematol Oncol Clin North Am; 2018 Aug; 32(4):713-728. PubMed ID: 30047422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of GATA2 deficiency syndrome.
    Calvo KR; Hickstein DD
    Blood; 2023 Mar; 141(13):1524-1532. PubMed ID: 36455197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GATA2 Is Dispensable for Specification of Hemogenic Endothelium but Promotes Endothelial-to-Hematopoietic Transition.
    Kang H; Mesquitta WT; Jung HS; Moskvin OV; Thomson JA; Slukvin II
    Stem Cell Reports; 2018 Jul; 11(1):197-211. PubMed ID: 29861167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA2 Deficiency Due to de Novo Complete Monoallelic Deletion in an Adolescent With Myelodysplasia.
    Vinh DC; Palma L; Storring J; Foulkes WD
    J Pediatr Hematol Oncol; 2018 May; 40(4):e225-e228. PubMed ID: 29620682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular and metabolic characteristics of pre-leukemic hematopoietic progenitors with GATA2 haploinsufficiency.
    Rein A; Geron I; Kugler E; Fishman H; Gottlieb E; Abramovich I; Giladi A; Amit I; Mulet-Lazaro R; Delwel R; Gröschel S; Levin-Zaidman S; Dezorella N; Holdengreber V; Rao TN; Yacobovich J; Steinberg-Shemer O; Huang QH; Tan Y; Chen SJ; Izraeli S; Birger Y
    Haematologica; 2023 Sep; 108(9):2316-2330. PubMed ID: 36475518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient hematopoietic redifferentiation of induced pluripotent stem cells derived from primitive murine bone marrow cells.
    Pfaff N; Lachmann N; Kohlscheen S; Sgodda M; Araúzo-Bravo MJ; Greber B; Kues W; Glage S; Baum C; Niemann H; Schambach A; Cantz T; Moritz T
    Stem Cells Dev; 2012 Mar; 21(5):689-701. PubMed ID: 21732815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-nucleotide human disease mutation inactivates a blood-regenerative GATA2 enhancer.
    Soukup AA; Zheng Y; Mehta C; Wu J; Liu P; Cao M; Hofmann I; Zhou Y; Zhang J; Johnson KD; Choi K; Keles S; Bresnick EH
    J Clin Invest; 2019 Mar; 129(3):1180-1192. PubMed ID: 30620726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.
    Ye Z; Zhan H; Mali P; Dowey S; Williams DM; Jang YY; Dang CV; Spivak JL; Moliterno AR; Cheng L
    Blood; 2009 Dec; 114(27):5473-80. PubMed ID: 19797525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of GATA2 Enhances Development and Maintenance of Human Embryonic Stem Cell-Derived Hematopoietic Stem Cell-like Progenitors.
    Zhou Y; Zhang Y; Chen B; Dong Y; Zhang Y; Mao B; Pan X; Lai M; Chen Y; Bian G; Zhou Q; Nakahata T; Zhou J; Wu M; Ma F
    Stem Cell Reports; 2019 Jul; 13(1):31-47. PubMed ID: 31178416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells.
    Ye Z; Liu CF; Lanikova L; Dowey SN; He C; Huang X; Brodsky RA; Spivak JL; Prchal JT; Cheng L
    Stem Cells; 2014 Jan; 32(1):269-78. PubMed ID: 24105986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic genetic rescue in hematopoietic cells in GATA2 deficiency.
    Catto LFB; Borges G; Pinto AL; Clé DV; Chahud F; Santana BA; Donaires FS; Calado RT
    Blood; 2020 Aug; 136(8):1002-1005. PubMed ID: 32556109
    [No Abstract]   [Full Text] [Related]  

  • 20. Heterogeneity of GATA2-related myeloid neoplasms.
    Hirabayashi S; Wlodarski MW; Kozyra E; Niemeyer CM
    Int J Hematol; 2017 Aug; 106(2):175-182. PubMed ID: 28643018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.